(From Briefing.com)
Gapping Down
Gapping down on disappointing earnings/guidance: CSCO -3.7%, SNDA -8%, CURE -34%, CSPI -33%, SRVY -31% (also multiple downgrades: Piper, Lehman, FBR), ECST -25% (also Merriman downgrade), ATAR -24%, HDTV -22%, MED -17%, LOUD -15%, SYMM -13%, NSTC -9%, ITWO -6%, RNAI -6%... Other news: BXXX -13% (prices offering), ONXX -5% (Pfizer submits application for competing drug Sutent, also gets fast-track designation), NIHD -4% (announces convertible offering), GILD -2.3% (says combo HIV drug fails to work as hoped), AMZN -1.4% (Legg Mason downgrade), HC -1.7% (prices offering at $14.25).Gapping Up
Gapping up on strong earnings/guidance: SMSI +6%, CELL +6%, AIG +2.5%.... Other News: BIDU +5% (up in sympathy with Yahoo's investment in Chinese e-commerce operator Alibaba.com), MSTR +3.5% (files 10-Q), ILSE +7% (Wachovia Upgrade), DPH +7% (JP Morgan upgrade), CKCM +3% (bounces after 27% drop yesterday), QCOM +3% (Morgan Stanley upgrade), OVTI +2.7% (collaborates with NASA), CHT +2% (privatizes with $2.56 bln US share offer), RMTI +25% (positive patent news).... Under $3: TMTA +48% (reports JunQ), QEE +21%.
Intraday Updates:
- 09:43 MORN and URBN have my attention
- 09:54 FWLT just hit the scanner
Disclaimer & How I use this list
Looks like MORN held up better than most through the reversal. Too bad I used a stop limit entry and missed out on it. Was worried it was a bit thin.
And I passed on it b/c of its wide spread :-(
"Ouch" on that reversal today. That was harsh.